Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial

• Main Authors: Jean T Coulibaly, PhD (Author), Gordana Panic, PhD (Author), Kigbafori D Silué, PhD (Author), Jana Kovač, MSc (Author), Jan Hattendorf, PhD (Author), Prof Jennifer Keiser, PhD (Author)
• Format: Book
• Published: Elsevier, 2017-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Praziquantel has been the drug of choice for schistosomiasis control for more than 40 years, yet surprisingly, the optimal dose for children younger than 4 years is not known. We aimed to assess the efficacy and safety of escalating praziquantel dosages in preschool-aged children (PSAC)....